Trial NCT01796470

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-339-0103

Last trial update was posted on 2020-06-02

MeSH Interventions

Idelalisib

MeSH Conditions

Hematologic Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell

Other Conditions

Chronic Lymphocytic Leukemia Diffuse Large B-cell Lymphoma Indolent Non-Hodgkin's Lymphoma Mantle Cell Lymphoma

Stopping Reasons

Study was terminated due to safety measures.

Limitations And Caveats

As a result of the early termination of the trial for safety, the efficacy endpoints were not evaluable due to insufficient treatment exposure.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID